Evaluation of an Interventional Module to Assist Physicians Introducing ACP to Cancer Patients

Cancer Patients Clinical Trial

Official title:

National Taiwan University Hospital,Taiwan (R.O.C)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04969952
• Other study ID #: 201912238RINA
• Status: Completed
• Phase: N/A
• Start date: April 6, 2021
• Est. completion date: December 20, 2023

Study information

• Verified date: June 2024
• Source: National Taiwan University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Evaluation of an Interventional module to assist physicians introducing ACP to cancer patients

Description:

Investigators hypothesize that compared to ACP brochure alone, educational module plus ACP brochure is effective in assisting the physicians to introduce ACP to the patients and completion of AD documentation

Recruitment information / eligibility

• Status: Completed
• Enrollment: 384
• Est. completion date: December 20, 2023
• Est. primary completion date: September 20, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 85 Years

Eligibility

"Inclusion Criteria" and "Exclusion Criteria"

Inclusion Criteria

1. Older than 20-years-old

2. Diagnosed with cancer

3. Have not signed any form of AD or DNR

Exclusion Criteria

1. Under 20-years-old

2. Can not speak or listen, difficult communication

3. Signed AD or DNR

Related Conditions & MeSH terms

• Cancer Patients

Intervention

Other:
• For interventional module
Using vedio to assist physicians introducing advance care planning to cancer patients

Locations

Country	Name	City	State
Taiwan	Nation Taiwan University Hospital	Taipei
Taiwan	National Taiwan University Hospital	Taipei county

Sponsors (1)

Lead Sponsor	Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Explain and predict health behaviors(Sign DNR / Completion AD)	To evaluate factors that might hinder patient willingness to sign DNR / complete AD documentation by applying the The Transtheoretical Model (TTM).	3 month
Primary	Sign DNR (Do-Not-Resuscitate)	After intervention cancer patients willing sing DNR	3 month
Secondary	Completion AD(Advance directive) documentation	After intervention cancer patients completion of a new AD documentation	3 month